Media Summary: Oleg Gluz, MD, Evang. Krankenhaus ""Bethesda"" Klinik, Mönchengladbach, Germany, discusses the use of circulating tumor ... Scott Kopetz, MD, PhD, FASCO, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the Matteo Carlino, FRACP, PhD, University of Sydney and Westmead Hospital, Sydney, Australia, discusses utilizing

Potential Role Of Ctdna For - Detailed Analysis & Overview

Oleg Gluz, MD, Evang. Krankenhaus ""Bethesda"" Klinik, Mönchengladbach, Germany, discusses the use of circulating tumor ... Scott Kopetz, MD, PhD, FASCO, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the Matteo Carlino, FRACP, PhD, University of Sydney and Westmead Hospital, Sydney, Australia, discusses utilizing Javier Garcia-Corbacho, MD, Hospital Clinic Barcelona, Barcelona, Spain, outlines the Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment. Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MOm discusses future approaches in the use of ...

Simpa Salami, MD, MPH, University of Michigan, Ann Arbor, MI, suggests further data is required prior to implementing Bishoy Faltas, MD, Weill Cornell Medicine, New York, NY, comments on the value of Alex Herrera, MD, City of Hope, Duarte, CA, discusses the growing Alexandra Drakaki, MD, PhD, University of California Los Angeles, Los Angeles, CA, emphasizes the critical

Photo Gallery

Potential role of ctDNA for early-stage breast cancer
Potential Use of ctDNA and MRD in CRC
What is Circulating Tumor DNA (ctDNA)?
What is the future role of ctDNA as a biomarker in colorectal cancer?
The potential applications of ctDNA in melanoma
The potential of ctDNA in oncology
Understand ctDNA Testing
Role of ctDNA in MRD
The potential applications of ctDNA in renal cell carcinoma
The importance of ctDNA as a bladder cancer biomarker
The emergence of ctDNA as a monitoring tool for endometrial cancer
The prognostic value of ctDNA-based MRD testing in lymphoma
Sponsored
Sponsored
View Detailed Profile
Potential role of ctDNA for early-stage breast cancer

Potential role of ctDNA for early-stage breast cancer

Oleg Gluz, MD, Evang. Krankenhaus ""Bethesda"" Klinik, Mönchengladbach, Germany, discusses the use of circulating tumor ...

Potential Use of ctDNA and MRD in CRC

Potential Use of ctDNA and MRD in CRC

John Marshall, MD, comments on the

Sponsored
What is Circulating Tumor DNA (ctDNA)?

What is Circulating Tumor DNA (ctDNA)?

For more info, visit: https://www.primrmed.com/cancer/general

What is the future role of ctDNA as a biomarker in colorectal cancer?

What is the future role of ctDNA as a biomarker in colorectal cancer?

Scott Kopetz, MD, PhD, FASCO, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the

The potential applications of ctDNA in melanoma

The potential applications of ctDNA in melanoma

Matteo Carlino, FRACP, PhD, University of Sydney and Westmead Hospital, Sydney, Australia, discusses utilizing

Sponsored
The potential of ctDNA in oncology

The potential of ctDNA in oncology

Javier Garcia-Corbacho, MD, Hospital Clinic Barcelona, Barcelona, Spain, outlines the

Understand ctDNA Testing

Understand ctDNA Testing

Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment.

Role of ctDNA in MRD

Role of ctDNA in MRD

Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MOm discusses future approaches in the use of ...

The potential applications of ctDNA in renal cell carcinoma

The potential applications of ctDNA in renal cell carcinoma

Simpa Salami, MD, MPH, University of Michigan, Ann Arbor, MI, suggests further data is required prior to implementing

The importance of ctDNA as a bladder cancer biomarker

The importance of ctDNA as a bladder cancer biomarker

Bishoy Faltas, MD, Weill Cornell Medicine, New York, NY, comments on the value of

The emergence of ctDNA as a monitoring tool for endometrial cancer

The emergence of ctDNA as a monitoring tool for endometrial cancer

... TX, discusses the

The prognostic value of ctDNA-based MRD testing in lymphoma

The prognostic value of ctDNA-based MRD testing in lymphoma

Alex Herrera, MD, City of Hope, Duarte, CA, discusses the growing

The role of ctDNA as a biomarker in bladder cancer treatment decisions

The role of ctDNA as a biomarker in bladder cancer treatment decisions

Alexandra Drakaki, MD, PhD, University of California Los Angeles, Los Angeles, CA, emphasizes the critical